Ovarian pathology and high incidence of sex cord tumors in follitropin receptor knockout (FORKO) mice

Endocrinology

Volumn 142, Issue 8, 2001, Pages 3673-3684

  Danilovich, Natalia ^a,b   Roy, Indrojit ^b   Sairam, M Ram ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; BODY WEIGHT; CACHEXIA; CONTROLLED STUDY; FEMALE; HETEROZYGOTE; HORMONE DETERMINATION; HYPERGONADOTROPIC HYPOGONADISM; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OVARY DISEASE; PRIORITY JOURNAL; SEX CORD TUMOR;

EID: 0034925724     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.8.8320     Document Type: Article

References (43)

1. Age contrast in ovarian pathology
2. Sex cord-stromal and steroid-cell tumors
3. Sex cord-stromal tumors of the ovary
4. The biology of ovarian cancer
5. The etiology and prevention of ovarian cancer
6. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors
7. α-inhibin is a tumour-suppressor gene with gonadal specificity in mice
8. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women
9. Fertility drugs and the risk of breast and ovarian cancers: Results of a long-term follow-up study
10. Hormonal screenings of hyperestrogenic, elderly, obese females for a granulosa cell tumor
11. Adenylate cyclase in human ovarian cancers: Sensitivity to gonadotropins and nonhormonal activators
12. Circulating hormone levels in a case of granulosa cell tumor
13. Hormonal control of gene expression in the ovary
14. Structural features and expression of an alternatively spliced growth factor type I receptor for follitropin signaling in the developing ovary
15. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure
16. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor
17. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cancers
18. Localization of gonadotropin binding sites in human ovarian neoplasms
19. Absence of mutations in the FSH receptor in ovarian granulosa cell tumors
20. An activating mutation of the follicle stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man
21. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
22. Impairing follicle-stimulating hormone (FSH) signaling in vivo. Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance
23. Qualitative and quantitative decline in spermatogenesis of the follicle stimulating hormone receptor knock-out (FORKO) mouse
24. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice
25. Sex cord-stromal and steroid cell ovarian tumors
26. The effect of a null mutation in the follicle stimulating hormone receptor gene on mouse reproduction
27. Pathogenesis of ovarian cancer: Role of ovulation and molecular changes
28. Luteinizing hormone induction of ovarian tumors: Oligogenic differences between mouse strains dictates tumor disposition
29. Effects of the unilateral or bilateral superior ovarian nerve section in prepubertal rats on the ovulatory response to gonadotrophins administration
30. The natural history and treatment of ovarian cancer
31. Ovarian stimulation and granulosa-cell tumour
32. Ovarian stimulation and granulosa-cell tumour
33. Ovarian stimulation and granulosa-cell tumour
34. Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice
35. Attempted induction of granulosa cell tumors in BALB/c mice by gonadotropin administration
36. Ovarian tumors not induced by irradiation and gonadotropins in hypogonadal (hpg) mice
37. Transgenic models to study gonadotropin function: The role of follicle-stimulating hormone in gonadal growth and tumorigenesis
38. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors
39. The link between female infertility and cancer: Epidemiology and possible aetiologies
40. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma
41. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors
42. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β